Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) develops, manufactures, and distributes products for the companion animal veterinary, livestock, poultry, dairy, and water testing markets. Valued at $44.6 billion by market cap, the company also operates an international network of veterinary reference laboratories. The global leader in pet healthcare innovation is expected to announce its fiscal second-quarter earnings for 2026 before the market opens on Tuesday, Aug. 4.
Ahead of the event, analysts expect IDXX to report a profit of $3.95 per share on a diluted basis, up 8.8% from $3.63 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.